AOD-9604 and 5-Amino-1MQ: How They Work

AOD-9604 and 5-Amino-1MQ get grouped together because people find them in the same place, filed under metabolic research. They have almost nothing else in common. One is a fragment of a human hormone. The other is not a peptide at all.

Both are worth understanding on their own terms, because the mechanisms are genuinely different from the GLP-1 class.

AOD-9604: a piece of growth hormone

Human growth hormone is 191 amino acids long, and it does several unrelated things. It drives growth and tissue building, largely through IGF-1. It also acts directly on fat tissue. Those two functions sit in different parts of the molecule.

In the 1990s, researchers mapped the fat metabolism activity to the tail end of the hormone, the stretch running from amino acid 176 to 191. AOD-9604 is that fragment, with a tyrosine added at the front end for stability. The name is short for Anti Obesity Drug 9604.

The point of using a fragment

Full growth hormone raises IGF-1 and affects insulin sensitivity and blood glucose. Those effects come from regions of the molecule that the 176-191 fragment does not contain.

So AOD-9604 does not bind the growth hormone receptor the way intact hGH does, and research has consistently found it does not raise IGF-1 or produce the glucose effects associated with the full hormone. Isolating the fragment isolates one activity and leaves the rest behind. That was the entire design goal.

What it does in fat tissue

The activity studied in adipose tissue runs in two directions. It stimulates lipolysis, the breakdown of stored triglycerides into fatty acids, and it inhibits lipogenesis, the process of building new fat stores.

Work in animal models and in isolated fat cells has connected this to beta-3 adrenergic receptor signaling in adipose tissue, a pathway distinct from the growth hormone receptor route.

AOD-9604 has also been studied outside metabolism entirely, in cartilage and joint research, where the interest is in its effects on chondrocytes rather than on fat.

5-Amino-1MQ: not a peptide

This one is worth stating plainly because the name and the company it keeps suggest otherwise. 5-Amino-1MQ is a small molecule, 5-amino-1-methylquinolinium. It has no amino acid chain and it is not built like a peptide.

It works as an enzyme inhibitor, and the enzyme is NNMT.

What NNMT does

NNMT stands for nicotinamide N-methyltransferase. It takes nicotinamide, a form of vitamin B3, and attaches a methyl group to it, producing 1-methylnicotinamide.

That reaction matters for two reasons. Nicotinamide is a precursor for NAD+, the coenzyme every cell uses in energy metabolism, so methylating it diverts material away from NAD+ production. The methyl group itself comes from SAM, S-adenosyl methionine, which is the cell’s main methyl donor for a long list of other reactions.

NNMT is expressed at high levels in adipose tissue and in the liver. Inhibiting it means less nicotinamide gets consumed and less SAM gets spent, which raises the available pool of both.

What the research has shown

Studies in mice have found that reducing NNMT activity in fat tissue, either by knocking the gene down or by using an inhibitor, produces smaller adipocytes and lower body weight in diet induced obesity models. The effect is tied to increased cellular NAD+ and to changes in how fat cells handle energy.

5-Amino-1MQ is orally available, which separates it from most compounds in this space. Peptides get broken down by digestion, which is why they are almost always injected. A small molecule does not have that problem, and 5-Amino-1MQ is supplied here in 10 mg and 50 mg formats.

Side by side

	AOD-9604	5-Amino-1MQ
Type	Peptide fragment, 16 residues	Small molecule
Origin	hGH amino acids 176-191	Synthetic quinolinium compound
Target	Adipose tissue signaling	NNMT enzyme
Effect on IGF-1	None reported	Not applicable
Route	Injected	Orally available

Common questions

Is AOD-9604 the same as growth hormone?

AOD-9604 is a 16 amino acid piece of the 191 amino acid hormone, specifically the 176-191 region plus an added tyrosine. It lacks the parts responsible for IGF-1 and growth signaling.

Does AOD-9604 raise IGF-1?

Research has consistently found that it does not. That separation is the reason the fragment was developed instead of using the full hormone.

Is 5-Amino-1MQ a peptide?

5-Amino-1MQ is a small molecule enzyme inhibitor rather than a peptide. It sits in the same product category because the research interest overlaps, not because the chemistry does.

What is NAD+ and why does it come up here?

NAD+ is a coenzyme central to energy metabolism in every cell. NNMT consumes nicotinamide, which is one of the raw materials for making NAD+, so inhibiting NNMT leaves more of that material available. You will also find NAD+ itself stocked directly.

TL;DR

AOD-9604 is the tail end of human growth hormone, cut out so the fat tissue activity comes without the IGF-1 and glucose effects of the full molecule. 5-Amino-1MQ is not a peptide at all. It blocks NNMT, an enzyme concentrated in fat tissue that consumes nicotinamide and SAM, and it works orally.

Everything we supply is lab tested for purity and identity, and sold as research grade material for laboratory and research use. Both sit in the GLP-1 and weight management range, alongside AOD in 5 mg and 10 mg vials.

Featured image by Håkan Dahlström, CC BY 2.0.